Business Context and Reporting Period
Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Three months ended March 31, 2002
Business Overview: The Company operates in the nutritional supplement market through an independent sales force of Managers and Distributors. Operations are segmented geographically into the United States, Latin America, Asia Pacific, and Other markets.
Key Financial Metrics
| Metric | Q1 2002 | Q1 2001 |
|---|---|---|
| Sales Revenue | $75.9 million | $81.7 million |
| Operating Income | $1.8 million | $6.4 million |
| Net Income (Loss) | $(0.9) million | $4.0 million |
| EPS (Diluted) | $(0.05) | $0.25 |
| Cash and Equivalents | $30.6 million | $33.1 million (End of Q1 2001) |
| Operating Cash Flow | $3.7 million | $10.1 million |
| Total Assets | $129.0 million | $131.4 million (Dec 31, 2001) |
| Total Liabilities | $35.5 million | $35.6 million (Dec 31, 2001) |
Margins: Operating margin decreased from 7.8% in Q1 2001 to 2.4% in Q1 2002. Net margin turned negative at -1.2% compared to 4.9% in the prior year.
Material Changes vs. Prior Period
- Revenue Decline: Sales revenue decreased 7.1% year-over-year. The U.S. segment declined 3% due to increased competition. International sales dropped 11%, driven by a 21% decline in Latin America (Brazil import restrictions and Venezuela currency devaluation) and a 2% decline in Asia Pacific.
- Profitability Collapse: Net income swung from a $4.0 million profit to a $0.9 million loss. This was primarily caused by a $3.0 million impairment charge on an investment in Cetalon Corporation and a 72.2% drop in operating income.
- Expense Pressure: Selling, General, and Administrative (SG&A) expenses increased 11.0% year-over-year, rising from 29.9% to 35.7% of sales. This was due to lower sales volume and $1.3 million in costs associated with "right-sizing" operations in Brazil and the U.S.
- Cash Flow: Net cash provided by operating activities decreased significantly to $3.7 million from $10.1 million in the prior year.
Guidance, Outlook, and Risks
- Outlook: Management expects competition to remain strong. SG&A expenses as a percent of sales are expected to return to prior-year levels for the remainder of 2002. Cost of goods sold and volume incentives are expected to remain relatively constant as a percentage of sales.
- Liquidity: The Company has no long-term debt or credit facilities. Management believes working capital needs can be met via cash on hand ($30.6 million) and internal funds, though a prolonged economic downturn could necessitate external funding.
- Capital Allocation: The Company repurchased approximately 169,000 shares of common stock for $2.1 million during the quarter. A quarterly dividend of 3 1/3 cents per share was declared.
- Risks: Significant exposure to foreign currency fluctuations (42% of revenue/expense is international). Specific risks include import restrictions in Brazil and currency devaluation in Venezuela. The Company does not use derivative instruments for hedging.
Investor Verification Checklist
- Investment Impairment: Verify the details and recoverability of the $3.0 million impairment charge on the Cetalon Corporation investment.
- Latin America Exposure: Assess the long-term impact of Brazilian import restrictions and Venezuelan currency devaluation on future revenue streams.
- SG&A Efficiency: Monitor whether SG&A expenses return to historical percentages of sales as management projects, given the recent "right-sizing" costs.
- Distributor Trends: Note the decline in total Distributors (from 596,000 to 570,000) despite a slight increase in Managers; evaluate the sustainability of the sales force.
- Currency Sensitivity: Review the impact of the strengthening U.S. dollar on international margins, as the Company does not hedge foreign exchange risk.